Reversible protonic ceramic cells (RePCCs) can facilitate the global transition to renewable energy sources by providing high efficiency, scalable, and fuel‐flexible energy generation and storage at the grid level. However, RePCC technology is limited by the lack of durable air electrode materials with high activity toward the oxygen reduction/evolution reaction and water formation/water‐splitting reaction. Herein, a novel nanocomposites concept for developing bifunctional RePCC electrodes with exceptional performance is reported. By harnessing the unique functionalities of nanoscale particles, nanocomposites can produce electrodes that simultaneously optimize reaction activity in both fuel cell/electrolysis operations. In this work, a nanocomposite electrode composed of tetragonal and Ruddlesden–Popper (RP) perovskite phases with a surface enriched by CeO2 and NiO nanoparticles is synthesized. Experiments and calculations identify that the RP phase promotes hydration and proton transfer, while NiO and CeO2 nanoparticles facilitate O2 surface exchange and O2‐ transfer from the surface to the major perovskite. This composite also ensures fast (H+/O2‐/e‐) triple‐conduction, thereby promoting oxygen reduction/evolution reaction activities. The as‐fabricated RePCC achieves an excellent peak power density of 531 mW cm‐2 and an electrolysis current of −364 mA cm‐2 at 1.3 V at 600 °C, while demonstrating exceptional reversible operation stability of 120 h at 550 °C.
Chemotherapy is widely recognized as an effective approach for treating cancer due to its ability to eliminate cancer cells using chemotherapeutic drugs. However, traditional chemotherapy suffers from various drawbacks, including limited solubility and stability of drugs, severe side effects, low bioavailability, drug resistance, and challenges in tracking treatment efficacy. These limitations greatly hinder its widespread clinical application. In contrast, supramolecular chemotherapy, which relies host–guest interactions, presents a promising alternative by offering highly efficient and minimally toxic anticancer drug delivery. In this review, we provide an overview of recent advancements in supramolecular chemotherapy based on host–guest interactions. We emphasize the significant role it plays in guiding cancer therapy. Drawing on a wealth of cutting‐edge research, we aim to present a timely and valuable resource for individuals interested in the field of supramolecular chemotherapy or cancer therapy. Furthermore, we aspire to contribute to progression of the field of supramolecular chemotherapy toward clinical application.This article is protected by copyright. All rights reserved
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.